(PharmaNewsWire.Com, April 23, 2018 ) Antifungal drugs are accustomed to counter fungus infections ensuing because of soggy, unhygienic, and unclean environments in which microscopic organisms like fungus thrive. Fungi multiply by spreading microscopic spores. The latter either infect the surface of the body like the skin or when inhaled and later resulting in fungal infections. fungal infections will damage superficial moreover as general regions of the body, like the eye, skin, mouth, and vagina.
The Europe Antifungal Drugs Market is estimated to have a value of USD 3.16 billion in 2016. With a CAGR of 3.4%, the market size is expected to grow rapidly to cross USD 3.73 billion by 2021.
The increasing incidences of fungal infections in this region and rising popularity and adoption of antifungal products are the major factors driving the growth in this market.
Among the drug classifications, azole occupied about 38% of the entire market share in 2016. This is the biggest share amongst all classifications and is predicted to follow this trend throughout the forecast period. The trend is happening because of rising awareness concerning drug accessibility and fungal infections.
Dermatophytosis holds the largest share because of rising incidence of skin infections in younger generations. Rising prevalence of longer-life fungal infections is anticipated to fuel the demand over the forecast period. However, the foremost usually occurring fungal infection is systemic candidiasis, that is predicted to exhibit the highest CAGR over the forecast period.
As of now, Europe with its growing technological advancements and growing awareness concerning fungal infections commandeered the second largest share of the global market share. This can be attributed to factors such as high concentration of key players situated in that region, especially in Germany.
The major market contributors for the Europe Antifungal Drugs Market are Alternaria, Pfizer, Novartis, Sanofi-Aventis, Merck & Co., Asperqillus, Kramer Laboratories, Bayer Healthcare, Enzon Pharmaceuticals, Glaxosmithkline Gilead and Abbott Laboratories
The scope of the report provides: • The evaluation of the current market for your product or services and the future implications of the market • Addresses the opportunities by better understanding the market through size estimates and growth rate analysis to forecast the market for the future • Extensive segmentation to understand the dynamics of market at a very granular level by splitting down the market to the smallest segment • Addresses the key market dynamics involving the drivers, restraints and challenges with an aim of providing insights for gaining market share • The factors responsible for the shaping of the industry as it is as a result of competitive environment is analyzed through Porter’s Five Forces • The effects of political, economic, social, technological, legal and environmental factors on the industry is analyzed through PESTLE analysis to better understand the aspects of strategic management required to comply with the exogenous and endogenous factors • Strategic evaluation of the key players to gain insights of their performance allowing access to their product portfolio, financial performance and the strengths of their business strategic developments • Comparative study of the firms across the industry measuring their performances based on market share and recent activities in order to achieve competitive intelligence • Equip you with the information providing with the investment opportunities in the industry
Looking for more? If you are in need of a specific research study, we have an expertise in undertaking a customized study and will aid to meet your research requirement to the fullest.
Contact Info: Name: Mr. Abhishek Shukla Email: abhishek@marketdataforecast.com Organization: MarketDataForecast™ Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India. Phone: +1-888-702-9626
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
